ANZCCP 2024 – Conference Day 1

Upon completion of the education, participants will be able to:

• Understand and explain the anatomy, physiology, and pathophysiology of the human body’s endocannabinoid system.
• Understand and explain the constituents of cannabinoid base medications.
• Refer to latest studies and TGA guidelines to ensure best practice diagnosis, management and referral options for the treatment with cannabinoid-based medicines of CNCP, Cancer pain and symptoms, MS, insomnia, anxiety, PTSD, and epilepsy.
• Understand safety considerations in prescribing cannabinoid-based medications, including, side effects, relative and absolute contraindications, drug interactions and safety. 
• Utilise best practice recommendations in medication selection, dosing, and titration for cannabinoid-based treatments.
• Select appropriate TGA prescribing pathways.
• Identify key health professionals to collaborate with in a multidisciplinary setting to support patients.
• Evaluate and communicate best practices for the daily administration of medicinal cannabis to patients.